Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

50.0%

2 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

75%

3 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(50.0%)
N/A
1(25.0%)
Phase 3
1(25.0%)
4Total
Phase 4(2)
N/A(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01478035Phase 4Terminated

Study on the Efficacy of Phenytoin in the Prophylaxis of Seizures of Patients With Pneumococcal Meningitis at Least 50 Yrs Old.

Role: collaborator

NCT02158923Not ApplicableCompleted

Individualized Perioperative Open Lung Ventilatory Strategy

Role: collaborator

NCT01299922Phase 3Withdrawn

Clinical Trial Treatment in Lupus Nephritis

Role: collaborator

NCT00356044Phase 4Completed

Arterial Access for Coronary Intervention in Myocardial Infarction

Role: lead

All 4 trials loaded